Silverarc Capital Management as of Sept. 30, 2022
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 75 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bellus Health Com New | 5.9 | $18M | 1.7M | 10.56 | |
Relmada Therapeutics Put Option (RLMD) | 4.9 | $15M | 393k | 37.02 | |
Prometheus Biosciences Put Option | 4.1 | $12M | 205k | 59.01 | |
Iveric Bio Put Option | 3.8 | $11M | 621k | 17.94 | |
Veracyte (VCYT) | 3.7 | $11M | 666k | 16.60 | |
Anavex Life Sciences Corp Com New Call Option (AVXL) | 3.6 | $11M | 1.0M | 10.32 | |
Akero Therapeutics (AKRO) | 3.5 | $10M | 300k | 34.05 | |
Morphic Hldg (MORF) | 3.1 | $9.2M | 324k | 28.30 | |
Cogent Biosciences (COGT) | 3.1 | $9.1M | 607k | 14.92 | |
Poseida Therapeutics I (PSTX) | 3.1 | $9.0M | 2.6M | 3.53 | |
Xenon Pharmaceuticals (XENE) | 3.0 | $8.9M | 246k | 36.10 | |
Aclaris Therapeutics (ACRS) | 2.9 | $8.6M | 544k | 15.74 | |
Viewray (VRAYQ) | 2.9 | $8.5M | 2.3M | 3.64 | |
Prothena Corp SHS (PRTA) | 2.4 | $7.0M | 115k | 60.63 | |
Mersana Therapeutics (MRSN) | 2.3 | $6.7M | 994k | 6.76 | |
Alnylam Pharmaceuticals (ALNY) | 2.2 | $6.5M | 33k | 200.15 | |
Female Health Put Option (VERU) | 2.1 | $6.3M | 550k | 11.52 | |
Intra Cellular Therapies (ITCI) | 2.1 | $6.3M | 136k | 46.53 | |
Apollo Endosurgery | 2.1 | $6.3M | 1.1M | 5.51 | |
Merus N V (MRUS) | 2.0 | $5.9M | 295k | 20.03 | |
Cerus Corporation (CERS) | 2.0 | $5.8M | 1.6M | 3.60 | |
Cti Biopharma | 1.9 | $5.7M | 984k | 5.82 | |
Clene Common Stock Put Option (CLNN) | 1.6 | $4.9M | 1.7M | 2.80 | |
Insmed Com Par $.01 (INSM) | 1.6 | $4.8M | 224k | 21.54 | |
Nkarta (NKTX) | 1.6 | $4.8M | 362k | 13.16 | |
Pliant Therapeutics (PLRX) | 1.5 | $4.4M | 210k | 20.89 | |
Acumen Pharmaceuticals (ABOS) | 1.4 | $4.2M | 420k | 10.03 | |
Krystal Biotech (KRYS) | 1.3 | $3.9M | 57k | 69.70 | |
Oric Pharmaceuticals (ORIC) | 1.3 | $3.9M | 1.2M | 3.20 | |
Mirati Therapeutics Call Option | 1.2 | $3.7M | 53k | 69.84 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $3.2M | 11k | 289.51 | |
Crinetics Pharmaceuticals In (CRNX) | 1.0 | $2.9M | 149k | 19.64 | |
Regenxbio Inc equity us cm (RGNX) | 1.0 | $2.9M | 110k | 26.43 | |
Cullinan Oncology (CGEM) | 1.0 | $2.9M | 225k | 12.82 | |
CVRX (CVRX) | 1.0 | $2.9M | 308k | 9.33 | |
Lava Therapeutics Nv SHS (LVTX) | 0.9 | $2.8M | 611k | 4.57 | |
Allakos (ALLK) | 0.8 | $2.4M | 400k | 6.12 | |
Seres Therapeutics (MCRB) | 0.8 | $2.4M | 367k | 6.42 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $2.4M | 187k | 12.60 | |
Karuna Therapeutics Ord | 0.8 | $2.3M | 10k | 224.93 | |
Point Biopharma Global | 0.8 | $2.3M | 300k | 7.73 | |
United Therapeutics Corporation (UTHR) | 0.8 | $2.2M | 11k | 209.42 | |
Phreesia (PHR) | 0.7 | $2.1M | 83k | 25.48 | |
Esperion Therapeutics (ESPR) | 0.7 | $2.1M | 314k | 6.70 | |
ImmunoGen | 0.7 | $2.1M | 439k | 4.78 | |
Arvinas Ord (ARVN) | 0.6 | $1.8M | 41k | 44.50 | |
Intellia Therapeutics (NTLA) | 0.6 | $1.8M | 32k | 55.95 | |
Immunovant (IMVT) | 0.6 | $1.7M | 300k | 5.58 | |
Immatics SHS (IMTX) | 0.6 | $1.6M | 164k | 10.00 | |
Bioatla (BCAB) | 0.5 | $1.5M | 200k | 7.70 | |
Celldex Therapeutics Com New (CLDX) | 0.5 | $1.5M | 53k | 28.12 | |
Seagen | 0.5 | $1.5M | 11k | 136.82 | |
89bio (ETNB) | 0.5 | $1.4M | 250k | 5.79 | |
Trevi Therapeutics (TRVI) | 0.5 | $1.4M | 939k | 1.54 | |
Amryt Pharma Sponsored Ads | 0.4 | $1.3M | 188k | 6.92 | |
Eliem Therapeutics (ELYM) | 0.4 | $1.3M | 402k | 3.23 | |
Altimmune Com New (ALT) | 0.4 | $1.3M | 101k | 12.77 | |
Ngm Biopharmaceuticals (NGM) | 0.4 | $1.2M | 95k | 13.08 | |
Codexis (CDXS) | 0.3 | $881k | 145k | 6.06 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.3 | $857k | 108k | 7.91 | |
Nuvalent Inc-a (NUVL) | 0.3 | $806k | 41k | 19.45 | |
Horizon Therapeutics Pub L SHS | 0.2 | $627k | 10k | 61.89 | |
Stereotaxis Com New (STXS) | 0.2 | $623k | 346k | 1.80 | |
Compass Therapeutics (CMPX) | 0.2 | $598k | 262k | 2.28 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.2 | $516k | 5.0k | 103.20 | |
Meiragtx Holdings (MGTX) | 0.2 | $465k | 55k | 8.40 | |
Macrogenics (MGNX) | 0.1 | $346k | 100k | 3.46 | |
Nucana Sponsored Adr (NCNA) | 0.1 | $282k | 270k | 1.05 | |
Praxis Precision Medicines I | 0.1 | $227k | 100k | 2.27 | |
Eloxx Pharmaceuticals | 0.1 | $187k | 1.1M | 0.17 | |
Evogene SHS (EVGN) | 0.0 | $139k | 168k | 0.83 | |
Terns Pharmaceuticals (TERN) | 0.0 | $85k | 15k | 5.87 | |
Polypid SHS Put Option | 0.0 | $59k | 50k | 1.18 | |
Renovacor *w Exp 99/99/999 | 0.0 | $8.0k | 105k | 0.08 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $999.800000 | 50k | 0.02 |